###begin article-title 0
###xml 69 75 69 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 473 479 473 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 549 555 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 834 840 834 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 962 968 962 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 455 459 <span type="species:ncbi:10090">Mice</span>
Alternative promoters usage is an important paradigm in transcriptional control of mammalian gene expression. However, despite the growing interest in alternative promoters and their role in genome diversification, very little is known about how and on what occasions those promoters are differentially regulated. Runx1 transcription factor is a key regulator of early hematopoiesis and a frequent target of chromosomal translocations in acute leukemias. Mice deficient in Runx1 lack definitive hematopoiesis and die in mid-gestation. Expression of Runx1 is regulated by two functionally distinct promoters designated P1 and P2. Differential usage of these two promoters creates diversity in distribution and protein-coding potential of the mRNA transcripts. While the alternative usage of P1 and P2 likely plays an important role in Runx1 biology, very little is known about the function of the P1/P2 switch in mediating tissue and stage specific expression of Runx1 during development.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">Mice</span>
We employed mice bearing a hypomorphic Runx1 allele, with a largely diminished P2 activity, to investigate the biological role of alternative P1/P2 usage. Mice homozygous for the hypomorphic allele developed to term, but died within a few days after birth. During embryogenesis the P1/P2 activity is spatially and temporally modulated. P2 activity is required in early hematopoiesis and when attenuated, development of liver hematopoietic progenitor cells (HPC) was impaired. Early thymus development and thymopoiesis were also abrogated as reflected by thymic hypocellularity and loss of corticomedullary demarcation. Differentiation of CD4/CD8 thymocytes was impaired and their apoptosis was enhanced due to altered expression of T-cell receptors.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
The data delineate the activity of P1 and P2 in embryogenesis and describe previously unknown functions of Runx1. The findings show unequivocally that the role of P1/P2 during development is non redundant and underscore the significance of alternative promoter usage in Runx1 biology.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">runt </italic>
###xml 113 126 113 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX1, RUNX2 </italic>
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX3 </italic>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 805 806 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 807 808 807 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 829 835 829 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 839 845 839 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx3 </italic>
###xml 945 946 945 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
The mammalian RUNX1 belongs to the runt domain family of transcription factors. The members of this gene family, RUNX1, RUNX2 and RUNX3 are key regulators of lineage-specific gene expression in major developmental pathways [1-3]. The three RUNX proteins recognize the same DNA-motif and regulate their target genes through interaction with a common group of transcriptional co-activators or co-repressors [4-7]. Interestingly, however, the functional overlaps are minor and each RUNX protein has a distinct subset of biological functions. Accordingly, each of the corresponding RUNX knockout (KO) mice displays a unique subset of phenotypic abnormalities [3]. This lack of functional redundancy results from a tightly regulated spatio/temporal expression mediated by an intricate transcriptional control [3,8]. For example, both Runx1 and Runx3 genes are expressed in developing dorsal root ganglia, but in different classes of sensory neurons [9-12] and both are expressed in mature T cells, but at different stages during T cell development [13-15].
###end p 9
###begin p 10
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 250 256 250 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 612 613 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
In the mouse embryo, expression of Runx1 is first detected in definitive hematopoietic stem cells (HSC) and in endothelial cells at HSC emergence sites [16-18]. These occurrences correlate well with the earlier findings that homozygous disruption of Runx1 results in a complete absence of fetal liver hematopoiesis [19,20]. Postnatally, Runx1 is highly expressed in several hematopoietic lineages including myeloid, B- and T-lymphoid cells [2,21,22] and is required for megakaryocytic maturation [23]. In contrast to the critical role of Runx1 during embryogenesis, it is less essential for adult hematopoiesis [2], albeit conditional inactivation is associated with a number of hematopoietic abnormalities including myeloproliferation [24].
###end p 10
###begin p 11
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 441 447 441 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 624 630 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GATA3 </italic>
###xml 680 682 680 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 729 735 729 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 775 781 775 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1084 1086 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1248 1250 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 384 399 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
Runx1 is also expressed in a number of other tissues at specific time windows during embryogenesis [2,3]. However, due to the early (E12.5) lethality of homozygous null Runx1 mice [16,19,20], relatively little is known about the function of Runx1 in these tissues. In developing thymus Runx1 is more abundantly expressed in the cortex [9,14] during early stages of thymopoiesis [13]. Transgenic mice that express a dominant-negative form of Runx1 display defects in maturation of single positive (SP) CD4 and SP CD8 thymocytes [25]. Additionally, naive T cells from these mice exhibited increased production of IL4, lack of GATA3 expression and enhanced Th2 differentiation of CD4+ helper-T cells [26]. Selective inactivation of Runx1 in T-cell progenitors demonstrated that Runx1 acts in double negative (DN) thymocytes to repress CD4 expression and to up-regulate CD8 as cells differentiate into the double positive (DP) thymocytes [13,27]. ES cells bearing a mutant Runx1 lacking the C-terminal repression sub-domain, failed to adequately contribute to the thymus in chimera mice [28]. In the knock-in model of this mutant, the overall number of thymocytes was significantly reduced and the thymus contained a higher proportion of SP CD4 cells [28].
###end p 11
###begin p 12
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 631 632 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 690 691 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 770 771 770 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1030 1036 1030 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1102 1104 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1293 1294 1293 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1446 1448 1446 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
We have previously shown that transcription of Runx1 is regulated by two distantly located promoter regions designated P1 and P2 for the distal and proximal, respectively [29]. The P2 is nested within a particularly large and evolutionary conserved CpG island [3,9], while no such CpG rich region is found in P1. The two promoters are regulated in a cell type-specific manner and respond to mitogenic stimulation [30,31]. The P1- and P2-derived primary transcripts are processed into a diverse repertoire of alternatively spliced mRNAs that are differentially expressed in various cell types and at different developmental stages [3]. The P1 and P2 mRNAs differ at their 5'-coding regions [9,31], and the resulting protein isoforms differ in their biological functions [1,32-34]. Similarly, a number of P2-derived splice-variants bear shorter reading frames that lack the transcriptional activation domain and can act in a dominant negative manner [31]. Forced expression of such isoforms results in transcriptional repression of Runx1 target genes [35-37], and in blocking of myeloid differentiation [36]. Hence, differential usage of P1 versus P2 has a profound effect on the repertoire and nature of Runx1 isoforms in the cell, which likely impacts on the regulation of Runx1 target genes [8]. Significantly, disruption of P1 by the 12;21 chromosomal translocation results in the most common subtype of childhood acute lymphoblastic leukemia [38].
###end p 12
###begin p 13
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 592 593 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 819 825 819 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 900 908 900 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1038 1044 1038 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
P1- and P2-transcripts also differ in the structure and function of their 5' untranslated region (5'UTR). The P1-5'UTR is relatively short and mediates cap-dependent translation, whereas the P2-5'UTR is particularly long, contains an internal ribosome entry site (IRES) and mediates cap-independent translation [3,30]. These structurally and functionally different 5'UTRs could have a profound effect on translation efficiency of Runx1 mRNAs. Indeed, in cell lines where P2 transcription predominated, P2-5' IRES-dependent translation was more efficient than P1-5' cap-dependent translation [3,30]. IRES-dependent translation is particularly important during development, in times when cap-dependent translation in proliferating or differentiating cells is down-regulated [39]. While it is clear that the regulation of Runx1 expression by alternative P1/P2 usage is a potentially key paradigm in the in vivo regulation of Runx1, very little is known about the role of the P1/P2 switch in mediating tissue and stage specific expression of Runx1 during development.
###end p 13
###begin p 14
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 149 158 149 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neomycin </italic>
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 223 227 223 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo </sup>
###xml 237 244 237 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo</sup>
###xml 1116 1122 1116 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">Mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
To investigate the biological function of the P1/P2 switch during embryogenesis, we generated mice bearing a hypomorphic Runx1 allele by inserting a neomycin (neo) gene into the P2 region (P2neo). Mice homozygous for the P2neo allele (P2neo/neo) displayed a markedly attenuated P2 activity. Nevertheless, these mutant mice developed to term, but newborns died within a few days after birth. We show that the P1/P2 switch is developmentally regulated and that the two promoters are alternatively used during embryogenesis. P2 mediated transcription is required during early thymopoiesis for the proper development of the thymus and for differentiation of DN and DP CD4/CD8 T cells. Attenuation of P2 activity results in impaired development of fetal liver hematopoietic precursors and in enhanced apoptosis of thymocytes due to altered expression of T-cell receptors (TCRs). The data describe previously unknown functions of Runx1, delineate the activity of P1 and P2 in embryogenesis, show unequivocally that their function during development is non redundant and underscore the significance of the two promoters in Runx1 biology.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 22 30 22 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Generation of Runx1 P2neo/neo mice and phenotypic analysis of mutant newborns
###end title 16
###begin p 17
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 330 336 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 438 444 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX1 </italic>
###xml 492 498 492 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX1 </italic>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 772 776 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 961 967 961 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 970 977 970 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Null mutation in Runx1 results in embryonal lethality [19,20]. As P2 activity starts early in embryogenesis (Levanon D. and Groner Y. unpublished), we envisaged a scenario in which germline inactivation of P2 will also result in embryonal death. To avoid this occurrence we explored means to selectively attenuate the activity of Runx1 P2. We have previously demonstrated that the genomic region upstream the transcription start sites of RUNX1 P2 was important for regulated transcription of RUNX1 in various cell lines [29,30]. We thus assessed whether insertion of a neo cassette into this region affects P2 activity in transfected cells (See additional file 1: Fig. 1A and 1B for constructs, results and methods). Transfection experiments indicated that insertion of a neo cassette into the P2 region specifically attenuated P2-mediated transcription in several cell lines and encouraged us to utilize this approach for evaluating the biological activity of Runx1 P2 in vivo.
###end p 17
###begin p 18
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 36 44 36 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Attenuated <italic>Runx1 </italic>P2 expression in P2<sup>neo/neo </sup>embryos impaired thymus development</bold>
###xml 150 158 150 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 200 208 200 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 249 257 249 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 398 406 398 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 503 511 503 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 586 594 586 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 667 673 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 773 779 773 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 793 801 793 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In-situ </italic>
###xml 840 848 840 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 982 990 982 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1126 1134 1126 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1187 1195 1187 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1312 1320 1312 1320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1415 1423 1415 1423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1580 1588 1580 1588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1714 1722 1714 1722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
###xml 1328 1332 <span type="species:ncbi:10090">mice</span>
###xml 1615 1619 <span type="species:ncbi:10090">mice</span>
Attenuated Runx1 P2 expression in P2neo/neo embryos impaired thymus development. (A) RT-PCR analysis of RNA from kidney and stomach of E16.5 WT and P2neo/neo embryos, and from tongue of P1.5 WT and P2neo/neo neonates. P2-mediated transcription in P2neo/neo tissues diminished, whereas P1-mediated transcription was largely unaffected. (B) IHC analysis of glandular stomach of E16.5 WT (left) and P2neo/neo (right) embryos. Runx1 expression is detected in epithelial cells of WT embryo, but missing in P2neo/neo littermate (10x magnification). (C) Reduced size of thymic lobes in P1.5 P2neo/neo mice (right) as compared to WT littermate (left). (D) RT-PCR analysis of Runx1 P1- and P2-mediated transcription in thymus of WT embryos, neonates and young mice. (E) Analysis of Runx1 expression by In-situ hybridization of E15.5 WT (left) and P2neo/neo (right) thymic sections, using the P2-5'UTR probe. P2-derived transcripts are clearly visible in the cortex of E16.5 WT, but not of P2neo/neo (10x magnification). (co) = cortex; (me) = medulla. (F) Western blot analysis of proteins extracted from thymus of E15.5-E17.5 WT and P2neo/neo embryos. Runx1 proteins were not detected in E15.5 P2neo/neo thymus, but gradually accumulated in E16.5 and E17.5 thymi. (G) Northern blot analysis of RNA from thymi of WT and P2neo/neo newborn mice. Whereas P2-mediated transcription (the 4 Kb and 8 Kb transcripts) [30, 31], in P2neo/neo thymocytes was markedly attenuated, P1-mediated transcription (the 2 Kb and 6 Kb transcripts) was apparently unaffected. (H) Reduced thymus cellularity in P2neo/neo embryos and neonates. Five mice of each genotype were analyzed. The difference between the number of thymocytes from WT and P2neo/neo thymus was significant at P < 0.0001 (*) and P < 0.05 (#) by Student's t test.
###end p 18
###begin p 19
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2A</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2B</xref>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 380 388 380 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo/+ </sup>
###xml 422 428 422 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 528 538 528 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo/neo </sup>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 599 607 599 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo/+ </sup>
###xml 610 615 610 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/+</sup>
###xml 711 716 711 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 716 726 716 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo/neo </sup>
###xml 729 736 729 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo</sup>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2D</xref>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
Runx1 P2 was targeted in ES cells using a construct in which the neo cassette was placed at the same site as in the P2neo-Ren construct (Additional file 1), but in a transcriptional orientation opposite to that of Runx1, and was flanked by lox P sites (Additional file 2A). Homologous recombination yielded ES clones (Additional file 2B), which were used to generate several Runx1P2neo/+ chimeric males that passed on the Runx1 mutation through the germ line. Mating F2 heterozygotes with 129/Sv, ICR or MF1 mice generated Runx1P2neo/neo mice with an inbred or a mixed background. Heterozygous Runx1P2neo/+ (P2neo/+) mice appeared phenotypically indistinguishable from their WT littermates. However, homozygous Runx1P2neo/neo (P2neo/neo) neonates were reduced in size, gained little weight and most of them died 2 to 3 days post natally (Additional file 2D).
###end p 19
###begin p 20
###xml 97 103 97 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/+ </sup>
###xml 176 180 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre </italic>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PGK </italic>
###xml 204 209 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EIIa </italic>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2B</xref>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP </italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XbaI </italic>
###xml 457 462 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 462 474 462 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2loxP/loxP </sup>
###xml 477 486 477 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP/loxP</sup>
###xml 587 595 587 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 635 639 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 149 164 <span type="species:ncbi:10090">transgenic mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
To further characterize the phenotype/genotype relationships of the mutant mice, heterozygotes P2neo/+ mice were mated with two different strains of transgenic mice expressing Cre driven by either PGK or EIIa promoters [40,41] (Additional file 2B). The resulting heterozygotes bearing the remaining loxP sequence within the P2-XbaI site were mated and offspring homozygous to P2-loxP were obtained at the expected Mendelian proportion (25%). Significantly, Runx1P2loxP/loxP (P2loxP/loxP) mice were indistinguishable form WT littermates indicating that the early lethality phenotype of P2neo/neo newborns was due to the presence of the neo cassette in the P2 region.
###end p 20
###begin title 21
###xml 33 41 33 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Attenuated Runx1 expression in P2neo/neo mice
###end title 21
###begin p 22
###xml 54 62 54 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 163 169 163 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 316 324 316 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 622 626 622 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo </sup>
###xml 663 669 663 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 1003 1011 1003 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
The above-described phenotypic manifestation of the P2neo/neo allele posed a question as to how the expression level of Runx1 was affected. To address this issue, Runx1 expression in various tissues was examined using RT-PCR, immunohistochemistry (IHC) and RNA in situ hybridization (RISH) (Fig. 1). In tissues of P2neo/neo mice, such as kidney and tongue, where Runx1 expression is normally mediated by both P1 and P2, only P1-transcripts were detected (Fig. 1A). In contrast, no Runx1 expression was detected by either RT-PCR or IHC in developing gastric epithelium where only P2 is normally active (Figs. 1A and 1B). P2neo is therefore a hypomorphic allele of Runx1 in which P2 activity is largely diminished. Interestingly, however, no developmental abnormalities were detected by macroscopic and histological examination of kidney, stomach and tongue of mutant embryos or newborns. The most obvious and consistent macroscopic abnormality was a profound reduction in size of the thymus of newborn P2neo/neo mice as compared to WT (Fig. 1C).
###end p 22
###begin p 23
###xml 150 156 150 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 270 278 270 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 584 592 584 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 640 646 640 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G</xref>
###xml 803 811 803 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
Western blot analysis, RISH using a P2 specific probe and RT-PCR showed that during early thymogenesis (embryonal day (E) 14.5-16.5) transcription of Runx1 in WT thymus was predominately mediated by P2 (Fig. 1D), and that at this stage almost no Runx1 was detected in P2neo/neo thymus (Figs. 1E and 1F). The P1 activity in WT thymus was switched-on between E15.5-E17.5 and persisted thereafter, whereas the activity of P2, which predominated during embryogenesis, gradually decreased after birth (Fig. 1D). Importantly, once switched-on the P1 activity was apparently unaffected in P2neo/neo mice, as evidenced by northern blot analysis of Runx1 mRNAs in newborns (Fig. 1G). Together, the complementary results of Runx1 expression studies and morphological analyses showed that expression of Runx1 in P2neo/neo mice was compromised both temporally and spatially, resulting in adverse effect on thymus development.
###end p 23
###begin title 24
###xml 39 47 39 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Impaired thymus development in Runx1 P2neo/neo mice
###end title 24
###begin p 25
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Thymus development in mouse embryo begins at E9.5 ensued by immigration of lymphocyte precursors into the thymic rudiment at E14.5. Development proceeds through stage specific interactions between thymocytes and thymic epithelium that are essential for the formation of thymic architecture [42]. Runx1 is highly expressed in developing thymocytes, but not in thymic epithelium [9,13,14].
###end p 25
###begin p 26
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2K</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1H</xref>
###xml 334 342 334 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 419 427 419 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 628 636 628 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 1201 1209 1201 1209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1296 1298 1296 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
Macroscopic examinations revealed that thymi of P2neo/neo neonates were about one-third of the normal size (Figs. 2I and 2K). This diminished size was caused by a profound reduction in the number of thymocytes during mutant thymus development (Fig. 1H). Histological examinations revealed no gross morphological differences between P2neo/neo and WT at E14.5 and E15.5 (Figs. 2A and 2C), except for scattered cysts in P2neo/neo thymi (Fig. 2C). These cysts are thought to result from accelerated epithelial turnover within centers of epithelial islands [43]. At E16.5 however, extensive histological differences between WT and P2neo/neo emerged (Fig. 2E). WT thymus had a clear demarcation of cortex and medulla. WT cortex was densely cellular with small hyperchromatic thymocytes, while the medulla was paler, contained a lower number of thymocytes admixed with macrophages, epithelial cells, and antigen presenting cells (Fig. 2E). Mutant thymus, on the other hand, was much smaller, hypocellular, had a scalloped capsular surface and consisted predominantly of epithelial cells, with no evidence of an organized cortex and medulla. At E17.5 the histological defects were even more pronounced; the P2neo/neo thymus still lacked corticomedullary organization and contained occasional cysts (Fig. 2G).
###end p 26
###begin p 27
###xml 64 72 64 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histological and IHC analysis of thymus development in WT and P2<sup>neo/neo </sup>mice</bold>
###xml 143 151 143 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 364 372 364 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 559 567 559 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Histological and IHC analysis of thymus development in WT and P2neo/neo mice. (A, C, E, G, I, K) Transverse sections of WT (left panels) and P2neo/neo (right panels) thymic lobes stained with hematoxylin and eosin (HE). co = cortex, me = medulla, scb = sub-cortical band, cy = cyst. (B, D, F, H, J, L) Immunostaining of Runx1 in sections of WT (left panels) and P2neo/neo (right panels) thymic lobes. Runx1 is detected in thymocytes, but not in thymic epithelium. A reduced number of Runx1 expressing thymocytes (that are abnormally distributed) is seen in P2neo/neo thymic lobes.
###end p 27
###begin p 28
###xml 101 109 101 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 189 191 189 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 443 451 443 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-situ </italic>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 486 494 486 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 643 644 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 648 650 648 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 732 733 732 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 737 739 737 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 794 802 794 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2J</xref>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2L</xref>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I</xref>
###xml 1116 1118 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2K</xref>
###xml 1223 1229 1223 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
IHC using anti Runx1 antibodies revealed a lower number of Runx1 positive cells in E14.5 and E15.5 P2neo/neo thymi compared to WT (Figs. 2B and 2D). Runx1 is mostly expressed in DN CD4-/CD8- immature thymocytes, where it regulates CD4 expression [13,25,28]. IHC of E15.5-E16.5 WT thymus revealed that these Runx1 positive immature thymocytes were predominantly in the cortex and less in the medulla (Figs. 2D and 2F), as also shown by the RNA in-situ hybridization data (Fig. 1E). In P2neo/neo thymus on the other hand, the fewer Runx1 positive cells were scattered randomly within the organ (Fig. 2D). At E17.5 most of Runx1 expressing DN CD4-/CD8- thymocytes were found in the sub-cortical band (SCB), whereas the cortical, DP CD4+/CD8+ thymocytes did not express Runx1 (Fig. 2H). In E17.5 P2neo/neo thymus, many Runx1 positive cells were still in the cortex and only after birth, when the mutant thymus gradually gained WT morphology, were Runx1 expressing hyperchromatic cells seen in the SCB (Figs. 2J and 2L). But even then, the overall size of mutant thymus remained much smaller compared to WT (Figs. 2I and 2K). The data indicate that normal embryonal thymopoiesis depends on a proper P2-mediated transcription of Runx1 which when attenuated during the E14.5-E16.5 time period results in impaired thymus development.
###end p 28
###begin title 29
###xml 35 43 35 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
Increased apoptosis in embryonal P2neo/neo thymocytes
###end title 29
###begin p 30
###xml 59 67 59 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 229 237 229 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 343 351 339 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 368 370 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 497 505 493 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 525 532 519 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo</sup>
###xml 553 555 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 593 601 585 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 717 725 707 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 791 793 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 798 800 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F</xref>
###xml 828 836 816 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 864 866 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 871 873 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 970 978 958 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1023 1025 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1056 1064 1044 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1112 1120 1100 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1276 1278 1264 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1337 1345 1325 1333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1451 1456 1439 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
To directly assess whether the thymic hypocellularity of P2neo/neo embryos was a consequence of enhanced cell death, the proportion of apoptotic thymocytes was determined by flow cytometry. At E14.5 a much higher proportion of P2neo/neo thymocytes (63% +/- 5) compared to WT (28% +/- 8) bound annexin V, indicating increased apoptosis among P2neo/neo thymocytes (Fig. 3A). Additionally, increased proportion of necrotic cells positive to both annexin V and propidium iodid (PI), was observed in P2neo/neo thymus (15% +/- 3 P2neo/neo; 10% +/- 2 WT, Fig. 3A). The enhanced cell death of E14.5 P2neo/neo thymocytes led to a three-fold reduction in the proportion of viable thymocytes in mutant thymus (WT 61.0% +/- 5; P2neo/neo 21.9% +/- 3). At E16.5-17.5 the P1 promoter is switched on (Figs. 1D and 1F), expression of Runx1 in P2neo/neo thymocytes increased (Figs. 2F and 2H) and recovery of thymopoiesis commenced. The end result was an increased proportion of viable P2neo/neo thymocytes at E17.5 almost to WT level (Fig. 3A). The enhanced apoptosis in P2neo/neo E14.5 and E15.5 thymus was also demonstrated by in situ TUNEL labeling and IHC of activated caspase-3 (not shown). The proportion of non-viable thymocytes at various stages of thymus development is shown in Fig. 3B. At early stages, apoptosis was significantly higher in P2neo/neo fetuses compared to WT, but gradually declined concomitant with the increase in P1-mediated expression of Runx1.
###end p 30
###begin p 31
###xml 2 10 2 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P2<sup>neo/neo </sup>thymocytes display enhanced apoptosis, but have normal cell proliferation capacity</bold>
###xml 154 162 154 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 364 365 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 368 369 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 403 404 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 407 408 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 415 423 415 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 436 444 436 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 572 580 572 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 677 685 677 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 827 835 827 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 941 949 941 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1048 1056 1048 1056 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1152 1153 1152 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 1172 1180 1172 1180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1275 1276 1274 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1365 1373 1364 1372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1683 1691 1682 1690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1711 1719 1710 1718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1868 1875 1867 1874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo</sup>
###xml 2033 2041 2032 2040 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 2098 2105 2097 2104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo</sup>
###xml 2159 2160 2158 2159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2197 2205 2196 2204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
P2neo/neo thymocytes display enhanced apoptosis, but have normal cell proliferation capacity. (A) FACS analysis of E14.5 and E17.5 WT (left panels) and P2neo/neo (right panels) thymocytes stained with Annexin V and PI. FACS dot plots and percentages of cells in each quadrant are indicated. Note the >2 fold increase in the proportion of apoptotic cells (Annexin V+/PI-) and of necrotic cells (Annexin V+/PI+) in P2neo/neo thymi. (B) P2neo/neo thymocytes display enhanced apoptosis throughout embryonic thymopoiesis. Proportion of non-viable (apoptotic+necrotic) WT and P2neo/neo cells gradually decreased during embryonic development. Nevertheless, at any given time point, P2neo/neo thymui contained a higher proportion of non-viable cells compared to WT littermates. After birth the proportion of non-viable thymocytes in P2neo/neo became similar to WT. At least five mice of each genotype were analyzed. The differences between WT and P2neo/neo apoptotic thymocytes were significant at P < 0.001 (*) and P < 0.01 (#) by Student's t test. (C) P2neo/neo thymocytes retain normal proliferation capacity. Following FACS analysis an equal number (1 x 104) of E15.5 WT or P2neo/neo Annexin V negative thymocytes were incubated with TPA (20 ng/ml) and ConA (5 mug/ml) for 48 h. 3H-thymidine was present during the last 18 h of incubation. Differences between WT and P2neo/neo were statistically insignificant by Student's t test. Proliferation capability of thymocytes was further examined by immunostaining of E15.5 thymic lobes for the proliferation-associated antigen recognized by Ki-67 antibodies (Right panels). (D) Enhanced embryonal apoptosis is a cell-autonomous property of P2neo/neo thymocytes. WT or P2neo/neo E15.5 FL HPC were differentiated under saturating conditions in E14.5 WT FTOC for 14 or 16 days. We predetermined that ~100 FL cells (either WT or P2neo/neo) per lobe were sufficient to populate all available thymic lobes and therefore used 1000 FL cells per lobe. Thymocytes accumulation in FTOC populated with P2neo/neo FL HPC is reduced compared to WT (left panel WT-black; P2neo/neo-white). Proportion of apoptotic thymocytes (Annexin V+) derived from FTOC populated with P2neo/neo FL cells (red) was considerably higher compared to WT (light blue) (right panel).
###end p 31
###begin p 32
###xml 54 62 54 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 186 195 186 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-vitro </italic>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 260 268 260 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 605 613 605 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 785 793 785 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 913 921 913 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
We next asked whether the proliferative capacity of P2neo/neo thymocytes was also affected. E15.5 thymocytes were isolated, analyzed by FACS and similar numbers of viable cells cultured in-vitro under proliferation stimulating conditions (Fig. 3C). Purified P2neo/neo and WT thymocytes displayed a similar thymidine incorporation rate, indicating that the ability of thymocytes to proliferate was hardly affected by the attenuated expression of Runx1 during early thymopoiesis. This conclusion was supported by immunostaining of thymocytes with the cell proliferation-associated antigen Ki-67. In E15.5 P2neo/neo thymus the number of Ki-67 positive cells was lower than in WT (Fig. 3C), reflecting the hypocellularity of mutant thymus (Fig. 2D). Nevertheless, significant numbers of P2neo/neo thymocytes did express Ki-67, indicating normal progression through the cell cycle. Together, these results show that P2neo/neo thymocytes possess proliferation and cell cycle progression capabilities similar to WT, but attenuating Runx1 expression during early developmental stages rendered thymocytes more susceptible to apoptosis, leading to thymic hypocellularity.
###end p 32
###begin p 33
###xml 48 56 48 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 153 161 153 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 310 318 310 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 505 513 505 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 599 607 599 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 635 640 635 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 739 745 739 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
To address whether the increased apoptosis of P2neo/neo thymocytes was due to loss of a cell-autonomous function of Runx1, we examined the capacity of P2neo/neo thymocytes to populate fetal thymic organ culture (FTOC). E14.5 WT thymic lobes were reconstituted, at a saturating cell number, with either WT or P2neo/neo E15.5 fetal liver (FL) cells that contain hematopoietic progenitor cells (HPC). At FTOC day 14 and 16, cells were extracted out of the lobes and analyzed by FACS for Annexin V binding. P2neo/neo HPC gave rise to a significantly lower number of FTOC cells compared to WT and most P2neo/neo derived cells were Annexin Vhigh (Fig. 3D). These data further demonstrated the intrinsic requirement for P2-mediated expression of Runx1 during early embryonal thymopoiesis.
###end p 33
###begin title 34
###xml 28 36 28 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
The enhanced apoptosis of P2neo/neo thymocytes is associated with increased expression of TCRbeta/TCRgammadelta
###end title 34
###begin p 35
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 116 124 116 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 271 273 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 444 446 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 447 449 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 574 582 549 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 612 614 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 619 621 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 685 687 657 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 704 706 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 776 784 737 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
The above results raised the question of how does attenuated expression of Runx1 cause the increased apoptosis of P2neo/neo thymocytes. The majority of immature thymocytes with a non-productive rearrangement of TCRbeta gene die through Fas/Fas ligand-mediated apoptosis [44]. Only a small subset of immature thymocytes with productive TCRbeta or gammadelta rearrangement are selected for further maturation associated with rapid proliferation [45-48]. Interestingly, the percentage of TCRbeta/TCRgammadelta expressing thymocytes was significantly higher in E14.5 to E17.5 P2neo/neo fetuses compared to WT (Figs. 4A and 4B), as was the mean-fluorescence-intensity (MFI) level of TCRbeta+ thymocytes (Fig. 4B). These data indicate an enhanced TCRbeta/gammadelta expression on P2neo/neo thymocytes compared to WT during the early stages of embryonal thymopoiesis.
###end p 35
###begin p 36
###xml 20 28 20 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 0 127 0 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The propensity of P2<sup>neo/neo </sup>thymocytes to undergo apoptosis is associated with elevated expression of TCR&#946; and TCR&#947;&#948;</bold>
###xml 191 199 169 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 286 294 264 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 452 460 417 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 562 570 527 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 748 756 702 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 803 811 757 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 920 922 871 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 924 932 875 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1055 1063 995 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1153 1161 1093 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1364 1372 1293 1301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1433 1441 1362 1370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1593 1595 1508 1510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1607 1609 1518 1520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1809 1811 1701 1703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1884 1892 1765 1773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1934 1938 1815 1819 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 2072 2074 1942 1944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">s </italic>
###xml 2222 2230 2090 2098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 2250 2252 2115 2117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2183 2187 <span type="species:ncbi:10090">mice</span>
The propensity of P2neo/neo thymocytes to undergo apoptosis is associated with elevated expression of TCRbeta and TCRgammadelta. (A and B) Expression of TCRbeta and TCRgammadelta on WT and P2neo/neo embryonal thymocytes. (A) Shown are FACS analysis dot plots of E15.5 to E18.5 WT and P2neo/neo thymocytes indicating the percentages of cells in each quadrant. Histograms in (B) show the average +/- S.E. of TCRbeta/TCRgammadelta proportions of WT and P2neo/neo thymocytes in at least three experiments at each developmental stage. The difference between WT and P2neo/neo was significant at P < 0.005 (*) and P < 0.05 (#) by Student's t test. While at E15.5 to E17.5 the proportion of TCRbeta/TCRgammadelta expressing thymocytes was much higher in P2neo/neo compared to WT, at E18.5 the distribution of P2neo/neo thymocytes resumed normal pattern. The mean fluorescence intensity (MFI) (B right) of E15.5 and E16.5 TCRbeta+ P2neo/neo thymocytes was significantly higher than WT (p < 0.005; by Student's t test). (C) Expression of TCRbeta/TCRgammadelta in P2neo/neo thymocytes is transcriptionally upregulated. RT-PCR analysis of RNA derived from WT and P2neo/neo E16.5 thymocytes using primers specific for the pre-TCRalpha and the constant regions of TCRbeta and TCRgamma transcripts. Increased number of PCR cycles shows elevated steady-state levels of mRNAs in P2neo/neo thymocytes compared to WT. (D and E) Enhanced apoptosis of P2neo/neo thymocytes is associated with elevated expression of TCRbeta/TCRgammadelta. (D) Histograms demonstrating the proportion of apoptotic cells among TCRbeta+ or TCRgdelta+ thymocytes. TCRbeta/TCRgammadelta positive WT thymocytes (blue) are divided into two main populations, apoptotic (M1) and non-apoptotic, according to level of Annexin V (except for E15.5 TCRgammadelta+ where all cells are apoptotic). Most of TCRbeta/TCRgammadelta positive P2neo/neo thymocytes (red), are at the M1 (Annexin Vhigh) apoptotic subset. (E) Proportion of apoptotic thymocytes among TCRbeta/TCRgammadelta positive E15.5, E16.5 and E18.5 thymocytes. Bars represent the average +/- S.E. of at least three independent experiments for each time point using different mice. The differences between WT and P2neo/neo in number of TCRbeta+ apoptotic thymocytes were significant at P < 0.01 (*) by Student's t test.
###end p 36
###begin p 37
###xml 82 83 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 213 221 210 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 382 390 357 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 445 447 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 512 514 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 519 521 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 552 553 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
Runx1 acts in transfected cells as a negative regulator of TCRbeta transcription [4]. It is thus possible that the diminished Runx1 expression between E14.5 to E16.5 caused de-repression of TCR transcription in P2neo/neo thymocytes, leading to the increased level of TCRbeta/gammadelta. Supporting this assumption are data demonstrating that upregulation of TCRbeta/gammadelta in P2neo/neo thymocytes occurred at the transcriptional level (Fig. 4C), and that down regulation to WT levels occurred at E18.5 (Fig. 4A and 4B), upon turning-on of P1 (Fig. 1).
###end p 37
###begin p 38
###xml 74 82 63 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 232 234 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 250 252 228 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 271 273 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 332 340 310 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 347 349 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 405 413 380 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 426 428 393 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 446 448 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 453 455 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 541 549 508 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 584 586 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 591 593 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 630 638 597 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 669 671 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 676 678 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 780 782 736 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 794 802 750 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 851 853 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 929 937 885 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
We next addressed whether increased expression of TCRbeta/gammadelta in P2neo/neo thymocytes was associated with the increased susceptibility to apoptosis of the mutant cells. Annexin V staining was monitored in fractionated TCRbeta+ or TCRgammadelta+ thymocytes (Figure 4D). In E15.5 and E16.5 embryos 50-65% of WT and 80-90% of P2neo/neo TCRbeta+ thymocytes were apoptotic as were ~95% of both WT and P2neo/neo TCRgammadelta+ thymocytes (Figs. 4D and 4E). Additionally, at these developmental stages a significantly higher proportion of P2neo/neo thymocytes express the TCRs (Figs. 4A and 4B). Thus, the enhanced apoptosis in P2neo/neo compared to WT thymus (Figures 3A and 3B), was closely associated with an increase in TCRbeta/gammadelta expression. Of note, MFI of Annexin V+ apoptotic P2neo/neo thymocytes, was lower compared to the WT (Figure 4D), presumably due to a lower level of cell surface phosphatidyl-serine in P2neo/neo cells.
###end p 38
###begin p 39
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 209 210 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 224 226 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 340 348 329 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
Together, the complementary outcome of these experiments indicates that Runx1 functions in vivo as a negative regulator of TCR expression. When the temporal expression of Runx1 is attenuated, levels of TCRbeta+/TCRgammadelta+ thymocytes increase, which may lead to enhanced cell death. When P1 is turned-on, restoring Runx1 expression in P2neo/neo cells, apoptosis in mutant thymocytes assumes normal levels.
###end p 39
###begin title 40
###xml 40 48 40 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
Impaired thymocyte differentiation in P2neo/neo embryos
###end title 40
###begin p 41
###xml 72 80 72 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 355 363 355 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 423 424 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 429 430 429 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 491 492 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 497 498 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 576 584 576 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 629 637 627 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 821 823 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 1015 1017 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
We next employed flow cytometry to study thymocyte differentiation in P2neo/neo embryos and neonates. First we examined the CD4/CD8 double negative (DN) population at E15.5 when nearly 100% of thymocytes are DN. The DN population is divided into four sub-groups, DN1 to DN4, according to the expression of CD25 and CD44 surface markers. Compared to WT, P2neo/neo embryos displayed an increase in the proportion of DN3 (CD25+/CD44-) thymocytes and a corresponding reduction in DN4 cells (CD25-/CD44-) (Fig. 5A), resulting in a significant increase in the ratio DN3/DN4 among P2neo/neo thymocytes (WT DN3/DN4 = 0.65 +/- 0.15 and P2neo/neo = 1.51 +/- 0.31; P < 0.001). To examine P1/P2 usage in the DN sub-groups we used flow cytometry to sort E15.5 thymocytes based on surface expression of CD25 and CD44 (as shown in Fig. 5A), and levels of P1 and P2 transcripts was determined. The levels of P1 and P2 expression did not differ significantly between DN3 and DN4 subgroups and was similar to the level shown in Fig. 1D.
###end p 41
###begin p 42
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P2-mediated expression of <italic>Runx1 </italic>is required for embryonal thymopoiesis</bold>
###xml 142 150 142 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 363 371 363 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
P2-mediated expression of Runx1 is required for embryonal thymopoiesis. (A) Distribution of CD44/CD25 expressing thymocytes of E15.5 WT and P2neo/neo embryos. Representative data of five different experiments are shown as FACS dot plots; percentages of cells in each quadrant are indicated. (B) Distribution of embryonic and neonatal CD4/CD8 thymocytes. WT and P2neo/neo thymocytes of E16.5 and E17.5 embryos and day 1.5 and 3.5 neonates were analyzed. Representative data of five different experiments are shown as FACS dot plots; percentages of cells in each quadrant are indicated.
###end p 42
###begin p 43
###xml 69 77 69 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 166 168 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 266 274 266 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 371 372 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 376 380 376 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 436 437 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 441 445 441 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 562 570 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cbf&#946; </italic>
###xml 578 580 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 623 624 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 628 632 625 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 720 724 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4 </italic>
###xml 763 765 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 797 805 794 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 867 869 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
Next we examined the CD8/CD4 double positive population. At E16.5, P2neo/neo embryos displayed a 2.5-fold reduction in the proportion of double positive (DP) CD4+/CD8+ thymocytes as compared to WT (Fig. 5B). At E17.5 the decrease in proportion of DP thymocytes in P2neo/neo embryos was more pronounced and accompanied by a marked increase in an abnormal population of CD4+/CD8low cells (Fig. 5B). A similar subpopulation of immature CD4+/CD8low was previously observed in mice with thymocyte specific targeting of Runx1 [13,28] and in mice bearing a hypomorphic Cbfbeta allele [49]. It was postulated that this abnormal CD4+/CD8low population represents immature DP thymocytes in which CD8 expression was diminished and CD4 expression was partially de-repressed [13]. Delayed differentiation of P2neo/neo thymocytes was still apparent at post-natal day (P) 1.5 (Fig. 5B), but recovery to WT proportions was noted at P3.5.
###end p 43
###begin p 44
###xml 167 168 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 172 176 172 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
Taken together, the change in the proportion of DN3/DN4 thymocytes at early thymopoiesis, the decrease in DP CD4/CD8 thymocytes and the increase in the abnormal SP CD4+/CD8low population, indicate that during embryonal thymopoiesis P2 activity is also required for regulation of CD4/CD8 expression and thereby for the proper differentiation of DN and DP thymocytes.
###end p 44
###begin title 45
###xml 53 61 53 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
Reduction in committed T-cell precursors (TCPs) in P2neo/neo fetuses
###end title 45
###begin p 46
###xml 56 60 56 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 142 151 142 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 335 343 335 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 414 422 414 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 561 569 561 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 608 617 608 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 690 698 690 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 794 802 794 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 876 884 876 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1005 1013 1005 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1083 1084 1081 1082 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1089 1091 1087 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1100 1101 1098 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1107 1109 1105 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1148 1150 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Runx1 is essential for embryonal hematopoiesis and Runx1-/- mice lack definitive hematopoiesis as well as hemapoietic colony forming activity in vitro [16,17,19,20]. In developing FL, Runx1 is expressed in HSC and in early progenitors [9,16,17], and in WT FL both promoters are active (Fig. 6A and [50]. In hematopoietic FL cells of P2neo/neo embryos, P1-transcription was not affected, as was noted earlier for P2neo/neo thymocytes (Fig. 1G), whereas P2 activity was largely attenuated (Fig. 6A). To assess hematopoietic activity, individual FLs from WT and P2neo/neo embryos were isolated and analyzed for in vitro colony formation. As shown in Fig. 6B, the number of colonies grown in P2neo/neo cultures was significantly lower compared to WT. However, because the size of the colonies in P2neo/neo and WT cultures was similar (data not shown), the results indicate that P2neo/neo FL cells contained fewer progenitors compared to WT. This conclusion was supported by the finding that E17.5 and E18.5 P2neo/neo embryos showed marked reduction (~50 +/- 3%) in the proportion of Gr-1+/CD18+ and CD11a+/CD11b+ cells compared to WT littermates (Fig. 6C and data not shown).
###end p 46
###begin p 47
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P2-mediated embryonal expression of <italic>Runx1 </italic>is required for development of FL HPC</bold>
###xml 140 148 140 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 188 196 188 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 507 515 505 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 575 583 573 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 704 712 702 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 819 827 817 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1029 1030 1027 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1035 1037 1033 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1046 1047 1044 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1053 1055 1051 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1084 1085 1082 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1091 1093 1089 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1122 1130 1120 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1168 1170 1166 1168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1199 1207 1197 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1433 1435 1431 1433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1461 1469 1459 1467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1527 1535 1525 1533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1539 1541 1537 1539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1647 1648 1645 1646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1654 1655 1652 1653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1660 1662 1658 1660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1687 1695 1685 1693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1714 1716 1712 1714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1829 1830 1827 1828 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1835 1838 1833 1836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 1842 1844 1840 1842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1859 1867 1857 1865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 2040 2048 2036 2044 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 2130 2138 2126 2134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 2198 2206 2194 2202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1973 1977 <span type="species:ncbi:10090">mice</span>
P2-mediated embryonal expression of Runx1 is required for development of FL HPC. (A) RT-PCR analysis of RNA from E13.5 FL cells of WT and P2neo/neo embryos. P2-mediated transcription in P2neo/neo was largely attenuated, whereas P1-mediated transcription was apparently unaffected. (B) Colony forming activity of FL hematopoietic stem/progenitor cells. Colonies (>30 cells in size) were scored on day 7 of incubation. Shown are average numbers of colonies per FL +/- S.E. of at least three different WT or P2neo/neo embryos at E12.5 and E13.5. The difference between WT and P2neo/neo colony number is significant (*) at P < 0.001 by Student's t test. (C and D) Altered expression of surface antigens on P2neo/neo FL HPC. (C) Expression profiles of Gr-1, CD18, CD11b, CD11a, CD44 and c-Kit, in FL HPC from E17.5 WT and P2neo/neo embryos. Representative data of at least three different experiments are shown as FACS dot plots; percentages of cells in each quadrant are indicated. Note the 2-fold decrease in the proportions of Gr-1+/CD18+ and CD11a+/CD11b+ (left panels) as well as CD44+/c-Kit+ (right panel), FL cells in P2neo/neo compared to WT. (D) Proportion of CD34+ FL HPC. Profiles of WT and P2neo/neo FL HPC, filled (blue) and unfilled (red) histograms, respectively, at E14.5, E16.5 and E18.5. Shown are representative results of at least three different experiments. Numbers at the upper right corners are percentages of CD34+ cells in WT (upper) and P2neo/neo (lower). Note the marked decrease in the proportions of P2neo/neo CD34+ HPC. (E) Analysis of committed FL T-cell precursors (TCPs). FACS analysis showing the distribution of B220+/c-Kit+/CD19- FL HPC of E15.5 WT and P2neo/neo embryos. Gated CD19- precursors (R1) were analyzed for c-Kit and B220 expression. Note the 4-fold decrease in the proportions of c-Kit+/B220low/D19- TCPs (R2) in P2neo/neo FL HPC. Data shown on the right are average +/- S.E. of four independent experiments using four different mice. The difference between the percentages of TCPs from WT and P2neo/neo FL HPC is significant at P < 0.005 by Student's t test. (F) Reduced capacity of P2neo/neo FL HPC to colonize FTOC. Isolated E15.5 FL HPC from WT or P2neo/neo embryos were set to differentiate, under limiting dilution conditions, for 16 days in E14.5 WT FTOC. Shown are percentage of unsuccessfully populated lobes per cultured cells and the calculated frequencies of three different independent experiments.
###end p 47
###begin p 48
###xml 37 45 37 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 173 181 173 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 241 243 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 426 429 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 441 443 441 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 708 716 708 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1H</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 824 832 824 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 867 870 867 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 876 877 876 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 882 884 882 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 953 961 953 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E</xref>
###xml 1119 1127 1119 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1176 1185 1176 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1277 1279 1277 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1280 1282 1280 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1290 1292 1290 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
###xml 1315 1323 1315 1323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1460 1468 1460 1468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1503 1511 1503 1511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1545 1547 1545 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
We next assessed the effect of the P2neo/neo hypomorph on the development of FL HPC. Runx1 expressing FL HPC also express CD34, c-Kit and CD44 [16,17]. In E17.5 and E18.5 P2neo/neo embryos, a 2-fold reduction in the proportion of CD44+/c-Kit+ HPC compared to WT littermates was observed (Fig. 6C), and even greater reduction was observed in CD34 positive cells at E14.5-E18.5 (Fig. 6D and data not shown). FL HPC that are B220low/c-kit+/CD19- represent an HPC population restricted to the T-cell and natural killer cell lineages [51]. These FL progenitors, termed T-cell precursors (TCPs), are thought to represent the immediate developmental step before thymic immigration. Because the hypocellularity of P2neo/neo thymus was noted at the earliest developmental stages (Figs. 1H and 2B), the proportion of TCPs in WT and P2neo/neo was compared. FACS analysis of B220low/c-kit+/CD19- E15.5 FL cells, revealed a fourfold reduction in the proportion of P2neo/neo TCPs compared to WT (Fig. 6E). These results indicated that the proportion of Runx1 expressing FL HPC, particularly the TCP subset, was markedly reduced in P2neo/neo compared to WT. This conclusion was supported by in vitro FTOC progenitor assay, which monitors the capacity of FL TCPs to reconstitute thymic lobes [51-54] (Fig. 6F). When E15.5 WT and P2neo/neo FL cells were cultured under limiting dilution conditions in FTOCs, the frequency of successfully populated thymic lobes was lower for P2neo/neo TCPs as compared to WT (~1 in 47 P2neo/neo cells vs. 1 in 28 WT cells) (Fig. 6F).
###end p 48
###begin p 49
###xml 130 138 130 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 226 230 226 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 281 283 281 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 289 291 289 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 362 370 362 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 394 402 394 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 484 492 484 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
Additionally, when day 16 FTOCs cells were obtained and CD4/CD8 positive cells analyzed by FACS, an abnormal differentiation of P2neo/neo thymocytes was observed with increased proportion of the abnormal population DP CD4+/CD8low and a twofold reduction in the proportion of SP CD4+ or CD8+ compared to WT (not shown). This FTOC result corresponds well with the in vivo delayed maturation of P2neo/neo fetal thymocytes described in Fig. 5. Collectively, these data indicate that in P2neo/neo embryos the development of FL HPC of different lineages was impaired.
###end p 49
###begin title 50
###xml 8 12 8 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo </sup>
###xml 78 82 78 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Runx1 P2neo allele failed to rescue the embryonal lethality phenotype of Runx1-/- mice
###end title 50
###begin p 51
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 178 186 178 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 295 303 295 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 365 369 365 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 595 597 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lz</sup>
###xml 599 604 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 604 610 604 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo </sup>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 625 630 625 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lz/+ </sup>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 650 657 650 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo/+</sup>
###xml 738 742 738 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo </sup>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 793 798 793 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 798 800 798 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lz</sup>
###xml 801 806 801 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 806 812 806 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo </sup>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 958 961 958 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 1195 1200 1195 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 1200 1204 1200 1204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1218 1220 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1221 1223 1221 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1423 1428 1423 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 1428 1432 1428 1432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1550 1552 1550 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1553 1555 1553 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1556 1558 1556 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
Homozygous disruption of Runx1 results in a complete absence of FL hematopoiesis and the mice die between E11.5 and E12.5 of hemorrhages in the central nervous system [19,20]. P2neo/neo mice were born and showed no sign of hemorrhages, indicating that expression levels of Runx1 in homozygous P2neo/neo during early embryogenesis were sufficient to rescue the Runx1-/- phenotype. This occurrence raised the question of whether Runx1 levels provided by activity of a single P1 will also be sufficient to rescue the null phenotype. To address this issue we generated a compound mutant strain Runx1lz; Runx1P2neo by mating Runx1lz/+ mice [16] with Runx1P2neo/+. These mice had one null allele expressing a fused Runx1-LacZ protein and one P2neo allele expressing WT P1 (Fig. 7A). Compound mutant Runx1lz;Runx1P2neo embryos died between E11.5 and E12.5 and suffered from hemorrhages in the nervous system (Fig. 7B). The most extensive bleedings was seen in the 4th ventricle, the ventral metencephalon and spinal cord. Moreover, the liver of E12.5 compound mutant embryos was depleted of hematopoietic cells (Fig. 7C), indicating lack of definitive hematopoiesis, similar to the previously reported Runx1-/- phenotype [16,19,20]. These results indicated, that during midgestation, angiogenesis and definitive hematopoiesis are highly sensitive to the dosage of Runx1 as activity of a single P1 was not sufficient to rescue the Runx1-/- phenotype. This conclusion is consistent with the previously reported data which was based on transplantation assays [17,18,55]. This observation may also pertain to the unique role of P2 activity during midgestation angiogenesis and/or early hematopoiesis.
###end p 51
###begin p 52
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 8 12 8 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo </sup>
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 78 82 78 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Runx1 </italic>P2<sup>neo </sup>allele failed to rescue the embryonal lethality phenotype of <italic>Runx1</italic><sup>-/- </sup>mice</bold>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 143 149 143 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lz</sup>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 221 226 221 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo</sup>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 237 239 237 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lz</sup>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 245 251 245 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo </sup>
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 386 388 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lz</sup>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 394 400 394 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo </sup>
###xml 483 486 480 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 700 705 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 705 707 702 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lz</sup>
###xml 708 713 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 713 719 710 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo </sup>
###xml 830 835 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 835 837 832 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lz</sup>
###xml 838 843 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 843 849 840 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo </sup>
###xml 918 924 915 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 995 999 992 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 999 1003 <span type="species:ncbi:10090">mice</span>
Runx1 P2neo allele failed to rescue the embryonal lethality phenotype of Runx1-/- mice. (A) Schematic representation of Runx1 locus in the two Runx1 mutant strains used to generate the compound mutant strain Runx1lz;Runx1P2neo. (B) Runx1lz;Runx1P2neo die at E11.5 to E12.5 due to hemorrhages in the CNS and/or lack of FL hematopoiesis. Left: Lateral view of a whole mount compound Runx1lz;Runx1P2neo E11.5 embryo stained for beta-galactosidase activity. Hemorrhages are seen in the 4th ventricle, the ventral metencephalon and spinal cord. Right: Hematoxylin and eosin (H&E) staining of a section through the spinal cord exhibits focal hemorrhage (arrow head). (C) H&E staining of WT (left view) and Runx1lz;Runx1P2neo (right view) E12.5 fetal liver. Note the absence of definitive hematopoietic precursors (deep purple cells) in Runx1lz;Runx1P2neo FL as compared to WT. The data demonstrate that activity of a single Runx1 P1 was not sufficient to rescue the embryonal lethal phenotype of Runx1-/- mice.
###end p 52
###begin title 53
###xml 31 39 31 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
Early lethality phenotype of P2neo/neo neonates is rescued by excision of the neo cassette in early T cell progenitors
###end title 53
###begin p 54
###xml 20 28 20 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 177 185 177 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 511 519 511 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 529 535 529 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1-</italic>
###xml 537 545 537 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 568 576 568 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lck-cre </italic>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 611 615 611 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 677 685 677 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 698 706 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lck-Cre </italic>
###xml 831 839 831 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lck-Cre </italic>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 1001 1005 1001 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 1094 1102 1094 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lck-Cre </italic>
###xml 1276 1284 1276 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lck-Cre </italic>
###xml 1295 1297 1295 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 1284 1288 <span type="species:ncbi:10090">mice</span>
As noted earlier, P2neo/neo neonates die within a few days after birth. The reasons for this early lethality are not clear. While P2-mediated expression diminished in several P2neo/neo tissues, including stomach, intestine and kidney (Fig. 1), the most striking abnormalities were noted in thymic development and thymopoiesis. We thus addressed whether these abnormalities could be rescued by specific removal of the neo cassette in early thymopoiesis and whether this occurrence will extend the life span of P2neo/neo neonates. Runx1-P2neo/neo mice were mated with a Lck-cre transgenic line [56] to excise the neo and regain P2 activity in thymocytes (Fig. 8A). Contrary to P2neo/neo mice, the P2/Lck-Cre mice developed normally and outwardly were indistinguishable from WT littermates. Nevertheless, embryonal thymopoiesis of P2/Lck-Cre was not completely normal and embryos exhibited a lower number of Runx1 expressing thymocytes (Figs. 8B and 8C). This may be due to an incomplete excision of the neo cassette in all T cell progenitors. Significantly, however, Runx1 expression level in P2/Lck-Cre was sufficient to allow for normal thymic development. Of note, P2-mediated Runx1 expression in other Runx1 expressing cells, such as epithelial cells, was not rescued in P2/Lck-Cre mice (Fig. 8D and data not shown).
###end p 54
###begin p 55
###xml 12 20 12 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rescue of P2<sup>neo/neo </sup>dependent thymic defect by T-cell specific removal of the <italic>neo </italic>cassette</bold>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 258 262 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 369 372 369 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 451 454 451 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 496 504 496 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 552 556 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 598 601 598 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 972 980 970 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1029 1037 1027 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1189 1195 1187 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 1257 1265 1255 1263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1495 1503 1493 1501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1637 1645 1635 1643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1805 1813 1803 1811 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 1827 1831 <span type="species:ncbi:10090">mice</span>
Rescue of P2neo/neo dependent thymic defect by T-cell specific removal of the neo cassette. (A) Specific excision of the neo cassette in P2/Lck-Cre mice. Southern blot analysis using a probe spanning the region indicated by the red bar assessed the level of neo excision in thymocytes, stomach epithelium and splenocytes of 4 week-old P2/Lck-Cre mice. The positions of XbaI cleavage sites are shown (X). The probe hybridized to a 3.4 Kb- and a 5.4 Kb XbaI genomic fragments derived from WT and P2neo/neo allele, respectively. Insertion/excision of the neo cassette by Lck-Cre eliminated the middle XbaI site (shown in WT as bold blue) generating the 4.6 Kb fragment derived from the P2/Lck-Cre allele. (B) Regeneration of thymus cellularity in P2/Lck-Cre mice. At day-1.5 the number of thymocytes in P2/Lck-Cre thymic lobes was near normal compared to WT littermates. Data shown are average +/- S.E. of five independent experiments using five mice of each genotype (WT, P2neo/neo and P2/Lck-Cre). The difference between WT and P2neo/neo is significant at P < 0.001 by Student's t test. (C) Recovery of thymopoiesis and thymic organogenesis in P2/Lck-Cre embryos. Histological analysis and Runx1 expression in thymic lobes derived from E15.5 and E16.5 WT, P2neo/neo and P2/Lck-Cre embryos. Shown are H&E stained transverse sections immunostained for Runx1. (D) Runx1 expression was not rescued in P2/Lck-Cre epithelial cells. IHC analysis of Runx1 expression in esophagi derived from E16.5 WT, P2neo/neo and P2/Lck-Cre embryos. Transverse sections showing Runx1 expression in epithelial cells lining the lumen of WT (arrow), but not of P2neo/neo or P2/Lck-Cre esophagus. Several other tissues including stomach and nasal cavity were similarly analyzed and revealed no expression of Runx1 in epithelia of P2neo/neo or P2/Lck-Cre mice (not shown).
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX1</italic>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 945 950 945 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX </italic>
###xml 1052 1064 1052 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegance </italic>
###xml 1137 1138 1137 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1139 1140 1139 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 612 617 <span type="species:ncbi:9606">human</span>
###xml 622 627 <span type="species:ncbi:10090">mouse</span>
Runx1 is an important cell-linage specific regulator of definitive hematopoiesis and thymopoiesis. The unique spatio/temporal expression pattern of Runx1 is attained through alternative usage of its two promoters, P1 and P2 [29,30,57] that also impacts on translation efficacy and repertoire of protein isoforms [30,57]. While it was clear that transcriptional regulation of Runx1 expression is an important element of its biological function, little was known about the role of the two promoters during development, and about how and when they are differentially regulated. Is the alternative promoter usage of human and mouse RUNX1/Runx1 a reflection of vertebrates' higher complexity? Differential usage of alternative promoters enables diversified transcriptional regulation within a single locus and may thus serve as a molecular basis for the higher complexity of certain vertebrates' systems, such as the immune system. Indeed, while the RUNX genes are highly conserved throughout the animal kingdom, more primitive animals such as the nematode C. elegance and the sea urchin contain only one gene regulated by a single promoter [3,8]. This single promoter is the equivalent of vertebrates' P2.
###end p 57
###begin title 58
Differential P1/P2 usage during embryogenesis
###end title 58
###begin p 59
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 455 461 455 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 793 801 793 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1002 1004 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1116 1124 1116 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 801 805 <span type="species:ncbi:10090">mice</span>
The use of hypomorphic alleles for studying essential genes at the organismal level is a well-established approach. We employed mice homozygous for a hypomorphic Runx1 allele, which caused a profound attenuation of P2 activity, to investigate the biological role of P2 during embryogenesis. Specifically, we analyzed the impact of the resulting hypomorphic Runx1 expression on FL HPC development and early thymopoiesis. We found that during embryogenesis Runx1 is developmentally regulated through alternative usage of P1 and P2. In certain tissues, including kidney, tongue and liver both P1 and P2 are active, whereas in others such as intestinal epithelium and early thymocytes P2 activity predominates. Contrary to Runx1 null mice, in which embryonic lethality occurs at ~E12.5 [19,20], P2neo/neo mice develop to term, implying that during early development the activity of P1 prevails. This conclusion is supported by the finding that both P1- and P2-transcripts are found in FL of E12.5 embryos [50]. The notion that both P1 and P2 are active during early hematopoiesis correlates well with the finding that P2neo/neo embryos displayed moderate and severe hematopoietic defects in the liver and thymus, respectively.
###end p 59
###begin title 60
P2 activity is essential for embryonal thymopoiesis and thymus development
###end title 60
###begin p 61
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 141 149 141 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-situ </italic>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 725 733 725 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Thymic development in the mouse begins at ~E9.5 [42]. Runx1 is highly expressed in thymocytes, but not in thymus epithelium [9,13,14]. Using in-situ hybridization, RT-PCR and IHC we demonstrate that during early thymopoiesis activity of P2 predominates. The P1 is upregulated at E17.5 and its activity persists thereafter, while the activity of P2 declines after birth. At E11 the thymic rudiment is colonized by the first wave of committed T-cell precursors (TCP) [54] which endure in the thymus until E17 [58]. It is tempting to speculate that P2 activity is confined to descendants of the first wave TCP, whereas P1 is active in thymocytes originating in the second wave. Consistent with this hypothesis, the first wave P2neo/neo thymocytes contained a markedly reduced level of Runx1 compared to WT, whereas in second wave thymocytes the level was similar to WT due to switch-on of P1 at E17.5. These second wave thymocytes grow exponentially after birth, when P1 is more active, and become the major cell population in the thymus.
###end p 61
###begin p 62
###xml 123 131 123 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 204 212 204 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 254 262 254 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
During early stages of thymus development (i.e. E14.4 to E16.5) a marked reduction in thymic cellularity was observed in P2neo/neo embryos. We show that this occurrence was due to enhanced apoptosis of P2neo/neo thymocytes. But why were E14.4 to E16.5 P2neo/neo thymocytes more susceptible to apoptosis than WT cells?
###end p 62
###begin p 63
###xml 452 454 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 455 457 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 704 706 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 707 709 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 710 712 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 764 772 761 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 853 861 850 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
Selection processes in the thymus ensure that peripheral T cells are responsive to foreign antigens but tolerant to self-antigens. This occurs through positive and negative beta-selections. Thymocytes, whose TCR engaged peptide/MHC molecules productively, escape their inherent programmed cell death and subsequently are induced to proliferate. On the other hand, thymocytes that react strongly with self-peptide-MHC molecules are actively eliminated [59-61]. According to the avidity model, selection occurs only when signals received through the TCR fall between two thresholds: signals below the one are incompatible with survival (death by neglect), while signals above the other result in deletion [47,62,63]. We hypothesize that the elevated TCR levels in P2neo/neo thymocytes disturbed this delicate balance and disposed a larger proportion of P2neo/neo T cells to apoptosis.
###end p 63
###begin p 64
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 306 314 306 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 539 544 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 544 547 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 609 613 609 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 692 700 692 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 812 818 812 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1041 1042 1041 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1043 1044 1043 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1092 1093 1092 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1094 1095 1094 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1176 1183 1176 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cbf&#946;</italic>
###xml 1277 1279 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
###xml 1139 1143 <span type="species:ncbi:10090">mice</span>
Several studies in transfected cells have demonstrated the involvement of Runx1 in transcription regulation of TCRs expression [8]. Specifically, we have shown that Runx1 can act as a transcriptional repressor in TCR regulation [4]. Thus, it is conceivable that the increased levels of TCRs in embryonic P2neo/neo thymocytes resulted from the reduced Runx1 expression in these cells, and that the higher TCRs levels lead to a higher avidity of TCR-MHC interactions, which programmed the cells to apoptosis. This hypothesis is supported by Runx1F/F/Lck-Cre mice, which show enhanced negative selection of Runx1-/- thymocyte [13], and by the finding that upon recovery of Runx1 expression in P2neo/neo thymocytes, TCR expression and apoptosis resumed WT levels. Potentially related, mice homozygous for a knock-in Runx1 cDNA that are lacking the C-terminal VWRPY, exhibit thymic hypocellularity [28]. The VWRPY motif, which is highly conserved among all RUNX proteins, is essential for recruitment of the transcriptional co-repressor Gro/TLE [4,7,64] and subsequent repression of target genes [4,7]. Thymic hypocellularity was also noted in mice bearing a hypomorphic allele of Cbfbeta, the non-DNA binding partner of Runx1, which is essential for the function of RUNX proteins [49].
###end p 64
###begin p 65
###xml 54 62 54 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 167 168 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 172 174 172 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 252 253 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 257 261 257 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 300 304 300 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 359 364 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 364 367 364 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F/F</sup>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4 </italic>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 506 507 506 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 511 515 511 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 558 565 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cbf&#946;</italic>
###xml 565 571 562 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">rss/- </sup>
###xml 600 608 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cbf&#946; </italic>
###xml 616 618 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 661 665 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4 </italic>
###xml 718 720 709 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 811 813 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 872 876 863 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4 </italic>
###xml 972 976 963 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4 </italic>
###xml 994 995 985 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
In addition to the marked hypocellularity, thymi of P2neo/neo embryos contained an increased proportion of DN3 (CD25+/CD44-) thymocytes, a reduced proportion of DP CD4+/CD8+ thymocytes and a pronounced increase in an abnormal population of immature CD4+/CD8low cells. The increase in DN3 and CD4+/CD8low thymocyte populations was previously observed in adult Runx1F/F/Lck-Cre mice due to diminished Runx1 in DN thymocytes and the consequent derepression of CD4 [13]. More recently a similar increase in CD4+/CD8low thymocytes was also observed in fetuses of Cbfbetarss/- mice bearing the hypomorphic Cbfbeta allele [49], indicating that Cbfbeta is required for CD4 silencing by Runx1. Abnormally high proportion of CD4+ thymocytes was also noted in embryos of the Runx1 knock-in mutant lacking the VWRPY motif [28]. This finding suggests that Runx1-mediated repression of CD4 in DN thymocytes involves the recruitment of Gro/TLE, as in case of Runx3-mediated silencing of CD4 in DP thymocytes [7].
###end p 65
###begin title 66
Attenuation of P2 activity affects development of FL HPC
###end title 66
###begin p 67
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 97 105 97 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 312 320 312 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 476 484 476 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 564 568 564 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 740 748 740 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 808 816 808 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 985 986 985 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 990 992 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 993 995 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 1047 1055 1047 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1125 1129 1125 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1135 1143 1135 1143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
Runx1 is essential for the emergence of embryonal HSC [16-18]. Analysis of FL hematopoiesis in P2neo/neo embryos revealed that the emergence and commitment of HPC to either myeloid or lymphoid lineages was not affected by attenuation of P2. However, the noted delay in differentiation and expansion of various P2neo/neo progenitor populations indicated that development of FL HPC was sensitive to diminution in P2 activity. Interestingly, the overall phenotype of FL HPC in P2neo/neo embryos resembled the phenotype observed by Cai et al [18] in heterozygous Runx1+/- fetuses, suggesting a gene dosage effect. In developing FL activity of P1 emerged early and persisted throughout gestation [50]. As P1 activity was largely unaffected in P2neo/neo HPC, it is conceivable that the hypomorphic expression in P2neo/neo FL creates conditions resembling haploinsufficiency [18], in line with the large body of literature documenting hematopoietic defects due to hemizygous dosage of Runx1 [2,17,20,65]. However, it is worth noting that the effect of P2neo/neo hypomorph is not merely through gene dosage, because contrary to Runx1+/- the P2neo/neo neonates die within a few days after birth.
###end p 67
###begin title 68
###xml 35 43 35 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
Rescue of the early lethality of P2neo/neo neonates
###end title 68
###begin p 69
###xml 63 71 63 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 217 225 217 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 279 287 279 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 344 346 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lz</sup>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Runx1</italic>
###xml 352 357 352 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo</sup>
###xml 594 602 594 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 707 711 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 734 740 734 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/+ </sup>
###xml 750 758 750 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lck-Cre </italic>
###xml 997 1004 997 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo</sup>
###xml 1081 1089 1081 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1255 1263 1255 1263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1293 1295 1293 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2C</xref>
###xml 1300 1302 1300 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2E</xref>
###xml 1400 1408 1400 1408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1628 1629 1628 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1699 1707 1699 1707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 1013 1017 <span type="species:ncbi:10090">mice</span>
###xml 1316 1325 <span type="species:ncbi:10090">nude mice</span>
Despite the diminished P2-activity and reduced Runx1 dosage, P2neo/neo embryos developed to term. Thus the residual P2 activity plus the apparent WT expression of P1 were sufficient to support normal development of P2neo/neo embryos through gestation. However, inactivation in P2neo/neo embryos of one P1 allele, as in the compound mutant Runx1lz;Runx1P2neo, which further reduced Runx1 dosage, caused hemorrhages in the nervous system and mid-gestation (E11.5-E12.5) lethality. This result defined the threshold level requirement of Runx1 for rescue of the nervous system hemorrhages. While P2neo/neo embryos developed to term, neonates die within a few days after birth. Specific removal of the floxed P2-neo cassette by crossing P2neo/+ mice with Lck-Cre transgenics resumed P2 expression in early thymopoiesis, allowed for normal thymic development and rescued the neonatal lethality. Of note, the neonatal lethality was rescued even though expression of P2 in the gastrointestinal tract of P2neo/neo/Lck-Cre mice was not resumed. This occurrence indicated that lethality of P2neo/neo neonates was not due to lack of Runx1 expression in gastrointestinal tract epithelium, despite the striking reduction of nutrients in the gastrointestinal tract of P2neo/neo neonates (see Additional File 2C and 2E). As athymic nude mice live through adulthood, it is conceivable that impaired thymopoiesis in P2neo/neo embryos, especially at the negative selection step, resulted in emergence of pathogenic T cells that cause the neonatal lethality. Finally, as the N-terminus of Runx1 proteins encoded by P2-mRNA differs from that of P1 [3], it is tempting to speculate that the hematopoietic phenotypes of P2neo/neo embryos were caused not only by gene dosage, but are due to the lack of P2 isoforms. Elucidating the specific role of the P1- and P2-protein isoforms in Runx1 biology, particularly early thymopoiesis, awaits further investigations.
###end p 69
###begin title 70
Conclusion
###end title 70
###begin p 71
###xml 253 259 253 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 683 691 683 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 721 729 721 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 847 853 847 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
Differential usage of alternative promoters enables diversification of transcriptional regulation within a single locus and thereby plays a significant role in the control of gene expression. During mouse embryogenesis the spatio/temporal expression of Runx1 is developmentally regulated by alternative usage of two mutually distinct promoters, P1 and P2. These promoters are not only differentially regulated, but also give rise to mRNAs with variant 5'-UTRs and to structurally different protein isoforms. Our studies support a model whereby attenuation of P2 affects mRNA levels and protein isoforms repertoire within the cell and thereby creates the hematopoietic phenotype of P2neo/neo embryos. The findings provide in vivo evidence for the non-redundant function of P1 and P2 and underscore the significance of alternative promoter usage in Runx1 biology.
###end p 71
###begin title 72
Methods
###end title 72
###begin title 73
###xml 22 30 22 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Generation of Runx1 P2neo/neo mice
###end title 73
###begin p 74
###xml 79 90 79 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoRI-PstI </italic>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 203 211 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pgk-neo </italic>
###xml 576 584 576 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1054 1058 1054 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 1082 1090 1082 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1194 1198 1194 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 1233 1237 1233 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 282 287 <span type="species:ncbi:10090">mouse</span>
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 1090 1094 <span type="species:ncbi:10090">mice</span>
###xml 1140 1145 <span type="species:ncbi:10090">mouse</span>
###xml 1177 1181 <span type="species:ncbi:10090">mice</span>
###xml 1259 1263 <span type="species:ncbi:10090">Mice</span>
###xml 1344 1348 <span type="species:ncbi:10090">mice</span>
Runx1 genomic clone was isolated from 129/Sv-derived ES cells DNA and a 7.2 Kb EcoRI-PstI fragment spanning 3 Kb upstream of P2, exon 2 and 2.4 Kb of intron 2 [57] was subcloned into pBluescript. A 2 Kb pgk-neo cassette was inserted into the XbaI site at nucleotide 27675861 of the mouse genome (accession # NT-039625). R1 ES cells were transfected with the targeting construct and homologous recombinants were evaluated by Southern blot analysis. Targeted ES cells were used to create several chimeras that passed the mutated Runx1 allele to their progeny. Two independent P2neo/neo mouse lines from two different ES clones were established and bred onto ICR and MF1 strains. As identical phenotypes were observed with mutant mice generated from either of the two-targeted ES cell lines, and with mutant mice bred on either ICR or MF1 background, in most cases we have combined the data. Genotypes were examined by PCR using genomic tail DNA and when applicable verified by Southern analysis. The noon of vaginal plug was considered E0.5. To remove the neo cassette, homozygotes P2neo/neo mice were crossed onto the transgenic Cre-deleter mouse strain PGK-Cre [40] generating mice lacking the neo cassette. Cre-mediated excision of neo was confirmed by PCR. Mice were bred and maintained in a pathogen-free facility. All experiments involving mice were approved by the Institutional Animal Care and Use Committee (IACUC) of the Weizmann Institute.
###end p 74
###begin title 75
Isolation of hematopoietic cells
###end title 75
###begin p 76
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Thymic lobes and livers of embryos or newborns were aseptically removed, and a single-cell suspension was generated. When required, red blood cells were lyzed with 1:9 volumes of PBS:RCLB (0.9% NH4Cl, 0.1% KHCO3, 0.0037% EDTA, pH7.2).
###end p 76
###begin title 77
Protein and RNA analysis
###end title 77
###begin p 78
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 177 179 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 410 416 410 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
Tissues were collected, washed once in PBS, and proteins or RNA were extracted. Protein extracts were subjected to Western blot analysis as described previously [30,35]. Poly(A)+ RNA was purified from 150 mg of total RNA using oligo(DT) magnetic beads (Dynal. Oslo, Norway) and subjected to Northern blot analysis as previously described [30,31]. WT thymocytes expressed four alternatively spliced isoforms of Runx1 transcripts, of which the 2 Kb- and 6 Kb result from P1-mediated transcription, while the 4 Kb- and 8 Kb from P2 activity [31].
###end p 78
###begin title 79
RNA preparation and RT-PCR analysis
###end title 79
###begin p 80
###xml 256 262 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 667 673 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 677 681 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCR </italic>
###xml 709 715 691 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 1171 1176 1126 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCRs </italic>
Total RNA isolated using Tri-Reagenttrade mark (MRC) was reverse transcribed using SuperScripttrade mark II reverse transcriptase (Invitrogen) and resulting cDNA was subjected to PCR reactions using the SuperTherm polymerase (Hoffman-La-Roche). To amplify Runx1 specific sequences, we used a common antisense primer that hybridizes to a sequence in the Runt domain exon 4 with two different sense primers that were complementary to either P1- or P2 5'UTR. Thereby the expression of both P1 and P2 regions were simultaneously monitored, providing a reliable readout of their relative expression levels. The sequences of primers and conditions used for PCR analysis of Runx1 and TCR are as follows: Primers for Runx1 amplification: 5'-GAAACGATGGCTTCAGACAGC-3' (P1-sense), 5'-CTTGGGTGTGAGGCCGATCC-3' (P2-sense), and 5'-ATGACGGTGACCAGAGTGCC-3' (runt domain antisense). beta-actin was used as an internal reference, with primers: 5'-GATGACGATATCGCTGCGCTG-3' (sense) and 5'-GTACGACCAGAGGCATACAGG-3' (antisense). The PCR conditions used were as follow: 94degreesC for 3 min, followed by 40 cycles of 94degreesC for 45 s, 57degreesC for 45 s and 72degreesC for 45 s. Primers for TCRs amplification: 5'-TCCTCCCCCAACAGGTAGCT-3' (Pre TCRalpha-sence), 5'-GGCAAACCACCAGCATGTG-3' (Pre TCRalpha-antisence), 5'-TCTCATAGAGGATGGTGGTGGCAGACA-3' (constant TCRb-sence), 5'-CTGCTACCTTCTGGCACAATCC-3' (constant TCRbeta-antisence), 5'-AGGCTTGATGCAGACATTTCCCCC-3' (constant TCRgamma-sence) and 5'-CTTGCCAGCAAGTTGTAGGCTTGG-3' (constant TCRgamma-antisence). The PCR conditions were as follow: 94degreesC for 3 min, followed by increasing number of cycles (25, 30, 35) of 94degreesC for 45 s, annealing for 45 s and 72degreesC for 60 s. Annealing temperatures were the following: 56degreesC-TCRalpha, 55degreesC-TCRbeta and 59degreesC-TCRgamma. All PCR products were analyzed by 1.5% agarose gel and visualized by staining with ethidium bromide.
###end p 80
###begin title 81
In-Situ hybridization
###end title 81
###begin p 82
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
In situ hybridization with Digoxigenin (DIG)-labeled antisense and sense Riboprobes made of the P2-5'UTR, spanning nucleotide No. 27,373,200-27,374,550 in Genbank Accession #  (see S1A), was performed according to published procedures [66], using 14 mu frozen sections. DIG labeled Riboprobes were detected by anti-DIG antibody conjugated to alkaline phosphatase (Roche), and developed with nitro blue tetrazolium/5-bromo-4-chloro-3-indole-phosphate.
###end p 82
###begin title 83
Histology and immunohistochemistry
###end title 83
###begin p 84
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 315 319 <span type="species:ncbi:9925">goat</span>
###xml 352 358 <span type="species:ncbi:9986">rabbit</span>
###xml 433 437 <span type="species:ncbi:9925">goat</span>
###xml 443 449 <span type="species:ncbi:9986">rabbit</span>
###xml 490 494 <span type="species:ncbi:9925">goat</span>
###xml 500 503 <span type="species:ncbi:10116">rat</span>
Histology and immunohistochemistry were performed as previously described [9,10]. Polyclonal anti Runx1 antibodies (1:1000) [9,35], and anti Ki-67 antibodies (1:50) (DakoCytomaion), were incubated overnight at room temperature in blocking solution of PBS containing 0.5% Triton X-100 and 3% heat inactivated normal goat serum for anti Runx1, or normal rabbit serum for anti Ki-67 [67]. Bound antibody was detected using biotinylated goat anti-rabbit IgG secondary antibodies for Runx1, and goat anti-rat IgG for Ki-67. The ABC complex from Vectastain kit (Vector Laboratories, Burlingame, CA) was used for peroxidase detection. Slides were counterstained with hematoxylin.
###end p 84
###begin title 85
Flow cytometric analysis
###end title 85
###begin p 86
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
Flow cytometry was performed as previously described [14,68], using the following mAbs from Pharmingen (San Diego, CA): CD4-FITC, CD8-PE, CD44-FITC, CD25-PE, TCRbeta-FITC, TCRbeta-biotinylated, TCRgammadelta-PE, c-KIT-PE, CD19-FITC, B220-biotinylated, Gr-1-FITC, CD18-PE, CD11a(LFA-1)-FITC, CD11b(Mac-1)-PE, CD34-FITC, streptavidin-APC.
###end p 86
###begin title 87
Proliferation assay and apoptosis analysis
###end title 87
###begin p 88
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 375 383 375 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
Proliferation assay was conducted as before [14]. 103 FACS sorted Annexin V negative cells were assayed for proliferation using [3H]thymidine (specific activity 25 Ci/mmole). Apoptosis was monitored by double staining with Annexin V and PI. Annexin V-FITC-conjugated anticoagulant (Annexin-V-Fluos Roche, Mannhein, Germany) was used according to manufacturer's instructions. In situ apoptotic cells were detected by staining paraffin sections of thymic lobes with ApopTag Apoptosis Detection System (Biotech). Activated caspase-3, a key apoptotic marker, was detected by IHC of paraffin sections with polyclonal antibodies against activated caspase-3 (Cell Signaling Technology).
###end p 88
###begin title 89
Fetal thymic Organ Culture (FTOC)
###end title 89
###begin p 90
###xml 143 151 143 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
Isolation of WT E14.5 thymic lobes, treatment with 1.35 mM 2'-deoxyguanosine (2-dG) (Sigma, St Louis, MO) and incubation of lobes with WT or P2neo/neo FL HPC by means of the hanging drop procedure, were performed as previously described [69]. After 16 days in organ culture, the lobes were removed, rinsed in medium and analyzed for newly populated thymocytes. Limiting dilution assay was performed as described by Jenkinson et al [52] and Dougai et al [51,54]. The frequency of TCPs per thymic lobe was deduced based on the Poisson probability distribution as previously described [51,54].
###end p 90
###begin title 91
Colony forming unit (CFU) assay
###end title 91
###begin p 92
###xml 2 4 2 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 101 106 <span type="species:ncbi:9796">horse</span>
105 FL cells were cultured in 1 ml of single layer DMEM culture medium containing 0.33% agar and 20% horse serum supplemented with 50 ng/ml stem cell factor, 20 ng/ml IL-3, 25 ng/ml IL-6, 5 ng/ml GM-CSF, and 2 ng/ml G-CSF to provide optimal conditions for multiplication and differentiation of multipotential hematopoietic progenitors of definitive hematopoiesis [19]. The number of colonies was determined after 7 days of incubation.
###end p 92
###begin title 93
Authors' contributions
###end title 93
###begin p 94
###xml 22 26 <span type="species:ncbi:10090">mice</span>
AP created the mutant mice, carried out the phenotypic analysis and drafted the manuscript. JL participated in hematopoietic progenitor differentiation analysis, assisted in data analysis and in drafting the manuscript. CX performed the in situ hybridization experiments. DG carried out protein analysis. OB analyzed the histology and immunohistochemistry data and conceived the pertained parts in the manuscript. VN and DL participated in molecular genetic studies and YG conceived and supervised the study, evaluated the data and wrote the manuscript. All the authors read and approved the final manuscript.
###end p 94
###begin title 95
Supplementary Material
###end title 95
###begin title 96
Additional file 1
###end title 96
###begin p 97
###xml 0 103 0 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insertion of a neo cassette into Runx1 P2 region inhibits transcriptional activity in transfected cells</italic>
###xml 0 103 0 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Insertion of a neo cassette into Runx1 P2 region inhibits transcriptional activity in transfected cells</italic></bold>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 356 359 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
Insertion of a neo cassette into Runx1 P2 region inhibits transcriptional activity in transfected cells. Two reporter plasmids were constructed (designated P2-Ren and P2neo-Ren) in which a Runx1 genomic region spanning 3 Kb upstream of P2 transcription start sites regulated the expression of Renilla luciferase gene. (A) Schematic drawing of P2-Ren and P2neo-Ren reporter plasmids. Both contained a genomic region which spans 3-kb upstream of P2 transcriptional start site (TSS), complete exon 2 and 2.4-kb of intron 2 [57]. The data show that in epithelial (HEK 293) and osteoblast (HOS) cell lines the inserted neo cassette had no effect on P2 activity whereas in T-cell (Jurkat), myeloid (U937) and neuronal (PC12) cell lines the neo cassette significantly attenuated the activity of Runx1 P2.
###end p 97
###begin p 98
Click here for file
###end p 98
###begin title 99
Additional file 2
###end title 99
###begin p 100
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 22 30 22 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Generation of <italic>Runx1 </italic>P2<sup>neo/neo </sup>mice and phenotypic analysis of mutant newborns</bold>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 180 184 180 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo </sup>
###xml 389 397 389 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-situ </italic>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 585 591 585 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">P2neo </sup>
###xml 594 597 594 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo</sup>
###xml 794 800 794 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 829 833 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 907 913 907 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 915 921 915 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/+ </sup>
###xml 947 951 947 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre </italic>
###xml 1035 1041 1035 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 1043 1051 1043 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1059 1067 1059 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1322 1330 1322 1330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1395 1403 1395 1403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1539 1545 1539 1545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/+ </sup>
###xml 1575 1583 1575 1583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1634 1642 1634 1642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1679 1687 1679 1687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1801 1809 1801 1809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1819 1823 1819 1823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 1905 1909 1905 1909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 1957 1965 1957 1965 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 1999 2007 1999 2007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo/neo </sup>
###xml 2047 2051 2047 2051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
###xml 951 966 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1330 1334 <span type="species:ncbi:10090">mice</span>
###xml 1403 1407 <span type="species:ncbi:10090">mice</span>
###xml 1545 1549 <span type="species:ncbi:10090">mice</span>
###xml 1653 1657 <span type="species:ncbi:10090">mice</span>
###xml 1809 1813 <span type="species:ncbi:10090">mice</span>
Generation of Runx1 P2neo/neo mice and phenotypic analysis of mutant newborns. (A, B) Scheme of genomic organization of Runx1 outlining the steps employed to generate the mutant P2neo locus and Southern blot analysis of genomic DNA identifying homologous recombination in ES clones and in newborn mutant mice. The region within P2-5'UTR (accession # D26532), which was used as a probe for in-situ hybridization is indicated on the targeting construct (striped bars), whereas the primers used for RT-PCR analysis are indicated on the genomic scheme (arrow heads). F1 heterozygotes Runx1P2neo (P2neo) were intercrossed and all three genotypes were detected in F2 litters. Transmission of the mutant allele roughly followed a Mendelian inheritance pattern, indicating that mice homozygous for the Runx1 mutant allele were born. The neo gene was excised (Mutant locus->Neo minus locus) by crossing heterozygous Runx1 P2neo/+ mice onto the appropriate Cre transgenic mice as described in results. (C) Early neonatal lethality of homozygous Runx1 P2neo/neo mice. P2neo/neo neonates exhibit marked growth retardation and die within few days after birth. At birth mutant mice were as active as their littermates, exhibited suckling behavior and had milk in their stomachs. However, at day 2 the amount of milk in the stomach of P2neo/neo mice drastically decreased. (D) Body weights of newborn WT and P2neo/neo mice during the first three days as observed in two litters (n = 14). Newborns were weighed at the indicated time after birth. WT and P2neo/+ mice gained weight, whereas P2neo/neo did not. (E) Stomach and duodenum of P2.5 WT and P2neo/neo littermate mice. Volume of milk in P2neo/neo stomach was significantly lower compared to WT. To further characterize the phenotype/genotype relationships in P2neo/neo mice, the neo gene was removed, as described in the results and shown in (B). As removal of the neo gene rescued the early lethality phenotype of P2neo/neo newborns, we concluded that the P2neo/neo phenotype resulted from the presence of neo in the P2 region.
###end p 100
###begin p 101
Click here for file
###end p 101
###begin title 102
Acknowledgements
###end title 102
###begin p 103
The authors thank Judith Chermesh, Rafi Saka and Shoshana Grossfeled for help in animal housbandry and Dorit Nathan, Tamara Berkuzki, and Eti Yael for technical assistance and Ayala Sharp and Eitan Ariel for help in FACS analysis. The work was supported by grants from the Commission of the EU (AnEUploidy), the Israel Science Foundation, and Shapell Family Biomedical Research Foundation at the Weizmann Institute.
###end p 103
###begin article-title 104
The Runx genes: lineage-specific oncogenes and tumor suppressors
###end article-title 104
###begin article-title 105
Core-binding factors in hematopoiesis and immune function
###end article-title 105
###begin article-title 106
Structure and regulated expression of mammalian RUNX genes
###end article-title 106
###begin article-title 107
Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors
###end article-title 107
###begin article-title 108
Role of RUNX family members in transcriptional repression and gene silencing
###end article-title 108
###begin article-title 109
Mammalian Groucho homologs: redundancy or specificity?
###end article-title 109
###begin article-title 110
Groucho/transducin-like Enhancer-of-split (TLE)-dependent and -independent transcriptional regulation by Runx3
###end article-title 110
###begin article-title 111
Upstream and downstream targets of RUNX proteins
###end article-title 111
###begin article-title 112
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis
###end article-title 112
###begin article-title 113
The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons
###end article-title 113
###begin article-title 114
Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain
###end article-title 114
###begin article-title 115
A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversification
###end article-title 115
###begin article-title 116
Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development
###end article-title 116
###begin article-title 117
Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis
###end article-title 117
###begin article-title 118
Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells
###end article-title 118
###begin article-title 119
Cbfa2 is required for the formation of intra-aortic hematopoietic clusters
###end article-title 119
###begin article-title 120
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo
###end article-title 120
###begin article-title 121
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo
###end article-title 121
###begin article-title 122
###xml 59 64 <span type="species:ncbi:9606">human</span>
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
###end article-title 122
###begin article-title 123
Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis
###end article-title 123
###begin article-title 124
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression
###end article-title 124
###begin article-title 125
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Runx1 is expressed in adult mouse hematopoietic stem cells and differentiating myeloid and lymphoid cells, but not in maturing erythroid cells
###end article-title 125
###begin article-title 126
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis
###end article-title 126
###begin article-title 127
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
###end article-title 127
###begin article-title 128
Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells
###end article-title 128
###begin article-title 129
The Runx1 transcription factor inhibits the differentiation of naive CD4+ T cells into the Th2 lineage by repressing GATA3 expression
###end article-title 129
###begin article-title 130
Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes
###end article-title 130
###begin article-title 131
###xml 83 89 <span type="species:ncbi:10090">murine</span>
VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoietic development
###end article-title 131
###begin article-title 132
###xml 18 23 <span type="species:ncbi:9606">human</span>
Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions
###end article-title 132
###begin article-title 133
Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms
###end article-title 133
###begin article-title 134
###xml 95 100 <span type="species:ncbi:9606">human</span>
A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1
###end article-title 134
###begin article-title 135
###xml 56 62 <span type="species:ncbi:10090">murine</span>
Expression and function of a stem cell promoter for the murine CBFalpha2 gene: distinct roles and regulation in natural killer and T cell development
###end article-title 135
###begin article-title 136
Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes
###end article-title 136
###begin article-title 137
Identification of an N-terminal transactivation domain of Runx1 that separates molecular function from global differentiation function
###end article-title 137
###begin article-title 138
###xml 30 35 <span type="species:ncbi:9606">human</span>
Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation
###end article-title 138
###begin article-title 139
An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms.
###end article-title 139
###begin article-title 140
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials
###end article-title 140
###begin article-title 141
Childhood acute lymphoblastic leukaemia--current status and future perspectives
###end article-title 141
###begin article-title 142
The role of the 5' untranslated region of an mRNA in translation regulation during development
###end article-title 142
###begin article-title 143
Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase
###end article-title 143
###begin article-title 144
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage
###end article-title 144
###begin article-title 145
Thymus organogenesis and molecular mechanisms of thymic epithelial cell differentiation
###end article-title 145
###begin article-title 146
###xml 52 58 <span type="species:ncbi:10090">murine</span>
TrkA is necessary for the normal development of the murine thymus
###end article-title 146
###begin article-title 147
Fas/Fas ligand signaling during gestational T cell development
###end article-title 147
###begin article-title 148
Peptides in positive and negative selection: a delicate balance
###end article-title 148
###begin article-title 149
T cell receptor antagonist peptides induce positive selection
###end article-title 149
###begin article-title 150
Specificity and flexibility in thymic selection
###end article-title 150
###begin article-title 151
TCR gene recombination and alpha beta-gamma delta lineage divergence: productive TCR-beta rearrangement is neither exclusive nor preclusive of gamma delta cell development
###end article-title 151
###begin article-title 152
T lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBF{beta} dosage
###end article-title 152
###begin article-title 153
Promoter specific targeting of Runx1 reveals new insights into Runx1 biology
###end article-title 153
###begin article-title 154
###xml 69 75 <span type="species:ncbi:10090">murine</span>
Identification of the earliest prethymic bipotent T/NK progenitor in murine fetal liver
###end article-title 154
###begin article-title 155
Effect of deoxyguanosine on lymphopoiesis in the developing thymus rudiment in vitro: application in the production of chimeric thymus rudiments
###end article-title 155
###begin article-title 156
###xml 48 54 <span type="species:ncbi:10090">murine</span>
Development of T cell precursor activity in the murine fetal liver
###end article-title 156
###begin article-title 157
###xml 53 59 <span type="species:ncbi:10090">murine</span>
Characterization of T cell precursor activity in the murine fetal thymus: evidence for an input of T cell precursors between days 12 and 14 of gestation
###end article-title 157
###begin article-title 158
A role for hematopoietic stem cells in promoting angiogenesis
###end article-title 158
###begin article-title 159
###xml 142 145 <span type="species:ncbi:9823">Pig</span>
Functional competence of T cells in the absence of glycosylphosphatidylinositol-anchored proteins caused by T cell-specific disruption of the Pig-a gene
###end article-title 159
###begin article-title 160
###xml 59 64 <span type="species:ncbi:9606">human</span>
Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1
###end article-title 160
###begin article-title 161
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Cell kinetics in the fetal mouse thymus: precursor cell input, proliferation, and emigration
###end article-title 161
###begin article-title 162
Positive selection of the T cell repertoire: where and when does it occur?
###end article-title 162
###begin article-title 163
The thymus and negative selection
###end article-title 163
###begin article-title 164
Positive and negative selection of T cells
###end article-title 164
###begin article-title 165
A differential-avidity model for T-cell selection
###end article-title 165
###begin article-title 166
Positive selection of thymocytes
###end article-title 166
###begin article-title 167
Groucho-dependent and-indenpendent repression activities of Runt domain proteins
###end article-title 167
###begin article-title 168
The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region
###end article-title 168
###begin article-title 169
A comparison of digoxigenin and biotin labelled DNA and RNA probes for in situ hybridization
###end article-title 169
###begin article-title 170
Epitope analysis of antibodies recognising the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein)
###end article-title 170
###begin article-title 171
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation
###end article-title 171
###begin article-title 172
Analysis of the development of T cells by transferring precursors into cultured fetal thymus with a microinjector
###end article-title 172

